UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED March 31, 2009.

OR

o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934

FOR THE TRANSITION FROM _______ TO ________.

COMMISSION FILE NUMBER 0-28353

INTEGRAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada
98-0163519
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)

805 W. Orchard Drive, Suite 7, Bellingham, Washington 98225
(Address of principal executive offices) (Zip Code)

Issuer's telephone number: (360) 752-1982

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 Large accelerated filer o
Accelerated filer o
   
Non-accelerated filer o
Smaller reporting company T

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o   No x

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
DURING THE PRECEDING FIVE YEARS
 
Indicate by check mark whether the registrant filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court. Yes o   No o

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date:  As of May 15, 2009, there were 50,305,769 outstanding shares of the Registrant's Common Stock, $0.001 par value.
 


 

 
INTEGRAL TECHNNOLOGIES, INC.
MARCH 31, 2009 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

     
Page
PART I - FINANCIAL INFORMATION
   
       
Item 1.
Financial Statements
   
       
INTEGRAL TECHNOLOGIES, INC.
   
 
(A Development Stage Company)
   
 
Consolidated Financial Statements
   
 
March  31, 2009
   
 
(U.S. Dollars)
   
 
(Unaudited)
   
       
 
F-1
 
       
 
F-2
 
       
 
F-3
 
       
 
F-4
 
       
 
F-5
 
       
Item 2.
 
1
Item 3.
 
3
Item 4T.
 
3
       
PART II - OTHER INFORMATION
   
       
Item 1.
 
3
Item 1A.
 
3
Item 2.
 
3
Item 3.
 
3
Item 4.
 
3
Item 5.
 
4
Item 6.
 
4
 
5



PART I
FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
 
INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Balance Sheet
(Unaudited)
(US Dollars)

 
March 31,
   
June 30,
 
 
2009
   
2008
 
         
Assets
       
 
       
Current
       
Cash
  $ 839,529     $ 1,104,104  
Prepaid expenses
    13,435       30,575  
 
               
Total Assets
  $ 852,964     $ 1,134,679  
 
               
Liabilities
               
 
               
Current
               
Accounts payable and accruals
  $ 625,993     $ 707,848  
 
               
Total Current Liabilities
    625,993       707,848  
 
               
Stockholders’ Equity
               
 
         
Preferred Stock and Paid-in Capital in Excess of $0.001 Par Value
         
20,000,000  Shares authorized
               
308,538  (June 30, 2008 - 308,538) issued and outstanding
    308,538       308,538  
Common Stock and Paid-in Capital in Excess of $0.001 Par Value
         
50,000,000  Shares authorized
               
50,305,769  (June 30, 2008 - 45,704,969) issued and outstanding
    30,439,046       29,219,711  
Promissory Notes Receivable
    (29,737 )     (29,737 )
Subscriptions Received
    0       276,500  
Other Comprehensive Income
    46,267       46,267  
Deficit Accumulated During the Development Stage
    (30,537,143 )     (29,394,448 )
 
               
Total Stockholders’ Equity
    226,971       426,831  
 
               
Total Liabilities and Stockholders’ Equity
  $ 852,964     $ 1,134,679  

See notes to consolidated financial statements.

F-1


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statement of Operations
(Unaudited)
(US Dollars)

                           
Period from
 
                           
February 12,
 
                           
1996
 
   
Three Months Ended
   
Nine Months Ended
   
(Inception) to
 
   
March 31,
   
March 31,
   
March 31,
 
   
2009
   
2008
   
2009
   
2008
   
2009
 
                               
Revenue
  $ 0     $ 0     $ 0     $ 0     $ 249,308  
Cost of Sales
    0       0       0       0       216,016  
 
    0       0       0       0       33,292  
Other Income
    1,829       11,435       7,882       52,996       864,978  
      1,829       11,435       7,882       52,996       898,270  
Expenses
                                       
Legal and accounting
    64,971       64,127       206,694       220,680       4,346,489  
Salaries and benefits
    129,000       140,999       433,558       429,260       9,535,650  
Consulting
    63,287       67,500       194,369       204,139       6,458,771  
General and administrative
    18,162       24,309       52,785       75,794       1,165,425  
Travel and entertainment
    9,613       28,975       41,070       75,992       1,344,416  
Bank charges and interest, net
    254       3,516       2,690       3,773       204,888  
Rent
    10,145       12,196       32,588       34,771       477,088  
Telephone
    6,784       6,853       20,103       22,600       454,405  
Advertising
    0       0       1,591       0       332,861  
Research and development
    43,234       53,317       153,549       185,260       1,394,452  
Settlement of lawsuit
    0       0       0       0       45,250  
Remuneration pursuant to proprietary, non-competition agreement
    0       0       0       0       711,000  
Financing fees
    0       0       0       0       129,043  
Write-off of investments
    0       0       0       0       1,250,000  
Interest on beneficial conversion feature
    0       0       0       0       566,455  
Write-down of license and operating assets
    0       0       0       0       1,855,619  
Bad debts (recovery)
    0       0       0       (6,009 )     46,604  
Amortization
    0       0       0       0       324,386  
      345,450       401,792       1,138,997       1,246,260       30,642,802  
Net Loss for Period
  $ (343,621 )   $ (390,357 )   $ (1,131,115 )   $ (1,193,264 )   $ (29,744,532 )
 
                                       
Loss Per Share
  $ (0.01 )   $ (0.01 )   $ (0.02 )   $ (0.03 )        
 
                                       
Weighted Average
                                       
Number of Common
                                       
Shares Outstanding
    47,705,871       45,519,969       46,832,273       45,518,914          

See notes to consolidated financial statements.

F-2


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statements of Stockholders' Equity (Deficit)
(US Dollars)

   
Shares of Common Stock Issued
   
Common Stock and Paid-in Capital in Excess of Par
   
Shares of Preferred
Stock Issued
   
Preferred Stock and Paid-in Capital in Excess of Par
   
Promissory Notes Receivable
   
Share Subscriptions
   
Other Comprehensive Income
   
Deficit Accumulated During the Development Stage
   
Total Stockholders' Equity (Deficit)
 
                                                       
Balance, June 30, 2007
    45,514,969     $ 28,762,772       308,538     $ 308,538     $ (29,737 )   $ 0     $ 46,267     $ (27,440,805 )   $ 1,647,035  
Shares Issued for
                                                                       
Exercise of warrants
    190,000       208,995       0       0       0       0       0       0       208,995  
Subscription received
    0       0       0       0       0       276,500       0       0       276,500  
Dividends on preferred shares
    0       0       0       0       0       0       0       (15,427 )     (15,427 )
Stock option compensation
    0       247,944       0       0       0       0       0       0       247,944  
Net loss for year
    0       0       0       0       0       0       0       (1,938,216 )     (1,938,216 )
                                                                         
Balance, June 30, 2008
    45,704,969     $ 29,219,711       308,538     $ 308,538     $ (29,737 )   $ 276,500     $ 46,267     $ (29,394,448 )   $ 426,831  
Shares Issued for
                                                                       
Past services (note 2(a))
    100,000       60,500       0       0       0       (46,500 )     0       0       14,000  
Shares issued
    4,500,800       1,125,200       0       0       0       (230,000 )     0       0       895,200  
Dividends on preferred shares
    0       0       0       0       0       0       0       (11,580 )     (11,580 )
Stock option compensation
    0       33,635       0       0       0       0       0       0       33,635  
Net loss for period
    0       0       0       0       0       0       0       (1,131,115 )     (1,131,115 )
                                                                         
Balance, March 31, 2009
    50,305,769     $ 30,439,046       308,538     $ 308,538     $ (29,737 )   $ 0     $ 46,267     $ (30,537,143 )   $ 226,971  

See notes to consolidated financial statements.

F-3


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Consolidated Statement of Cash Flows
(Unaudited)
(US Dollars)

         
Period from
 
         
February 12,
 
         
1996
 
   
Nine Months Ended
   
(Inception) to
 
   
March 31,
   
March 31,
 
   
2009
   
2008
   
2009
 
Operating Activities
             
Net loss
  $ (1,131,115 )   $ (1,193,264 )   $ (29,744,532 )
Items not involving cash
                       
Write-down of investment
    0       0       1,250,000  
Proprietary, non-competition agreement
    0       0       711,000  
Amortization
    0       0       349,941  
Other income
    0       0       (658,305 )
Consulting services and financing fees
    14,000       0       1,537,783  
Stock option compensation
    33,635       0       5,747,929  
Interest on beneficial conversion feature
    0       0       566,456  
Settlement of lawsuit
    0       0       60,250  
Write-down of license and operating assets
    0       0       1,853,542  
Bad debts
    0       0       77,712  
Changes in Non-Cash Working Capital
                       
Due from affiliated company
    0       0       (116,000 )
Notes and account receivable
    0       0       (109,213 )
Inventory
    0       0       (46,842 )
Prepaid expenses
    17,140       3,540       (13,435 )
Other
    0       0       (2,609 )
Accounts payable and accruals
    (93,435 )     3,829       887,413  
Cash Used in Operating Activities
    (1,159,775 )     (1,185,895 )     (17,648,910 )
Investing Activities
                       
Purchase of property, equipment and intangible assets
    0       0       (200,935 )
Assets acquired and liabilities assumed on purchase of subsidiary
    0       0       (129,474 )
Investment purchase
    0       0       (2,000,000 )
License agreement
    0       0       (124,835 )
Cash Used in Investing Activities
    0       0       (2,455,244 )
Financing Activities
                       
Redemption of preferred shares
    0       0       (50,000 )
Repayment of loan
    0       0       (11,000 )
Repayments to stockholders
    0       0       (91,283 )
Proceeds from issuance of common stock
    895,200       208,995       19,095,670  
Advances from stockholders
    0       0       1,078,284  
Share issue cost
    0       0       (227,420 )
Subscriptions received
    0       0       1,398,365  
Proceeds from convertible debentures
    0       0       600,000  
Cash Provided by Financing Activities
    895,200       208,995       20,897,416  
Effect of Foreign Currency Translation on Cash
    0       0       46,267  
Inflow (Outflow) of Cash
    (264,575 )     (976,900 )     839,529  
Cash, Beginning of Period
    1,104,104       2,240,356       0  
Cash, End of Period
  $ 839,529     $ 1,263,456       839,529  

See notes to consolidated financial statements.

F-4


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Notes to Consolidated Financial Statements
Nine Months Ended March 31, 2009
(Unaudited)
(US Dollars)

1.
BASIS OF PRESENTATION

These unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information.  These financial statements are condensed and do not include all disclosures required for annual financial statements.  The organization and business of the Company, accounting policies followed by the Company and other information are contained in the notes to the Company’s audited consolidated financial statements filed as part of the Company’s June 30, 2008 Form 10-KSB.

In the opinion of the Company’s management, these consolidated financial statements reflect all adjustments necessary to present fairly the Company’s consolidated financial position at March 31, 2009 and June 30, 2008 and the consolidated results of operations and cash flows for the three and nine-months ended March 31, 2009 and 2008.  The results of operations for the three and nine-months ended March 31, 2009 and 2008 are not necessarily indicative of the results to be expected for the entire fiscal year.

2.
STOCKHOLDERS’ EQUITY

 
(a)
Common stock

During the nine-month period ended March 31, 2009, the Company issued 50,000 shares as consideration for consulting services.  These shares were recorded at a value of $14,000 representing the market value of the shares at the date when the shares were to be issued.

During the nine-month period ended March 31, 2009, the Company issued 50,000 shares as consideration for consulting services.  These shares were recorded as subscriptions received during the year ended June 30, 2008 at a value of $46,500 representing the market value of the shares at the date when the shares were to be issued.

During the nine-month period ended March 31, 2009, the Company received $1,125,200 for issuance of 4,500,800 units, each unit consisting of one share of common stock at $0.25 per share and one warrant at $0.001 per share.  Each warrant entitles the holder to purchase one share of common stock on or before December 31, 2010 at an exercise price of $0.50 per share.

F-5


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Notes to Consolidated Financial Statements
Nine Months Ended March 31, 2009
(Unaudited)
(US Dollars)

2.
STOCKHOLDERS’ EQUITY (Continued)

 
(b)
Stock options

The following table summarizes the Company's stock option activity for the nine-month period ended March 31, 2009:

               
Weighted
 
               
Average
 
   
Number
   
Price
   
Exercise
 
   
of Options
   
Per Share
   
Price
 
                   
Balance, June 30, 2008
    3,720,000     $ 0.50 to $ 2.75     $ 1.31  
Granted during the period
    0     $ 0.00     $ 0.00  
Expired
    (350,000 )   $ 1.00 to $2.75     $ 2.25  
Exercised
    0     $ 0.00     $ 0.00  
 
                       
Balance, March 31, 2009
    3,370,000     $ 0.50 to $ 2.25     $ 1.21  

The following summarizes the options outstanding and exercisable, which were fully vested at these dates:

         
Number of Options
 
   
Exercise
   
March 31,
   
June 30,
 
Expiry Date
 
Price
   
2009
   
2008
 
                   
August 31, 2009
  $ 0.65 to $ 1.16       855,000       855,000  
November 15, 2009
  $ 1.00       100,000       100,000  
March 23, 2009
  $ 1.00       0       100,000  
March 30, 2009
  $ 2.75       0       250,000  
June 30, 2010
  $ 0.50       1,000,000       1,000,000  
June 30, 2010
  $ 2.25       1,000,000       1,000,000  
December 31, 2010
  $ 1.00       415,000       415,000  
 
                       
Total outstanding
  $ 0.50 to $ 2.25       3,370,000       3,720,000  
Total exercisable
  $ 0.50 to $ 2.25       3,276,250       3,626,250  
 
F-6


INTEGRAL TECHNOLOGIES, INC.
(A Development Stage Company)
Notes to Consolidated Financial Statements
Nine Months Ended March 31, 2009
(Unaudited)
(US Dollars)

2.
STOCKHOLDERS’ EQUITY (Continued)

 
(c)
Stock purchase warrants

The following table summarizes the Company's stock purchase warrant activity for the nine-month period ended March 31, 2009:

               
Weighted
 
               
Average
 
   
Number
   
Price
   
Exercise
 
   
of Warrants
   
Per Share
   
Price
 
                   
Balance, June 30, 2008
    400,269     $ 2.00     $ 2.50  
Issued
    4,500,800     $ 0.50     $ 0.50  
Expired
    (400,269 )   $ 2.50     $ 2.50  
 
                       
Balance, March 31, 2009
    4,500,800     $ 0.50     $ 0.50  

The following stock purchase warrants were outstanding:

         
Number of Warrants
 
   
Exercise
   
March 31,
   
June 30,
 
Expiry Date
 
Price
   
2009
   
2008
 
                   
September 15, 2008
  $ 2.50       0       400,269  
December 31, 2010
  $ 0.50       4,500,800       0  

 
(d)
Stock based compensation

During the nine-month period ended March 31, 2009, the Company extended the expiry date of 955,000 options.  These options have been re-measured resulting in $33,635 additional compensation expense recognized in the period, $15,531 is included as part of salaries and benefits and $18,104 is included as part of consulting fees.

The fair value of each option grant is calculated using the following weighted average assumptions:

       
Expected life (years)
    1  
Interest rate
    3.87 %
Volatility
    84.24 %
Dividend yield
    0.00 %
Forfeiture rate
    0.00 %
 
F-7

 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS AND  PLAN OF OPERATIONS

Statements contained herein that are not historical facts are forward-looking statements.  Although we believe that the expectations reflected in such forward-looking statements are reasonable, the forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from those projected.  We caution investors that any forward-looking statements made by us are not guarantees of future performance and that actual results may differ materially from those in the forward-looking statements.  Such risks and uncertainties include, without limitation: well-established competitors who have substantially greater financial resources and longer operating histories, regulatory delays or denials, ability to compete as a start-up company in a highly competitive market, and access to sources of capital.

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included elsewhere in this Form 10-Q. Except for the historical information contained herein, the discussion in this Form 10-Q contains certain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. The cautionary statements made in this Form 10-Q should be read as being applicable to all related forward-looking statements wherever they appear in this Form 10-Q.  Our actual results could differ materially from those discussed here.

To date we have recorded nominal revenues. We are still considered a development stage company for accounting purposes. From inception on February 12, 1996 through March 31, 2009, we have accrued an accumulated deficit of approximately $30.5 million.

At March 31, 2009, all of our assets were current assets of $852,964 consisting of cash of $839,529 and prepaid expenses of $13,435.  All of our property and equipment has been fully depreciated.

At March 31, 2009, all of our liabilities were current liabilities of $625,993, consisting of accounts payable and accruals.  Of this amount, payables for legal fees (including associated filing fees) related to patent filings accounted for approximately $535,000 of the total.

At March 31, 2009, total stockholder’s equity was $226,971.

For the Three Months Ended March 31, 2009 compared to the Three Months Ended March 31, 2008

Our net loss for the quarter ended March 31, 2009, was $343,621, compared to a net loss of $390,357 for the corresponding period of the prior fiscal year, a decrease of $46,736 which was primarily a result of a reduction in general and administrative expenses of $6,147, travel and entertainment expenses of $19,362 and a reduction of research and development costs of $10,083.

Total expenses for the quarter ended March 31, 2009, was $345,450 compared to total expenses of $401,792 for the corresponding period of the prior fiscal year a reduction of $56,342 which was primarily a result of a reduction in general and administrative expenses of $6,147, travel and entertainment expenses of $19,362 and a reduction of research and development costs of $10,083.

Total income for the quarter ended March 31, 2009, was comprised of “other income” of $1,829 compared to “other income” of $11,435 for the corresponding period of the prior fiscal year, a decrease of $9,606.  The category of “other income” consists of interest income and nominal license fees.

Consulting expenses during the quarter ended March 31, 2009, were $63,287 which included non-cash, issuance of shares in consideration for consulting services in the amount of $14,000 representing the market value of the shares at the date when the shares were to be issued. In the corresponding period of the prior fiscal year, consulting expenses were $67,500, which included non-cash, stock based compensation charges of $nil.

Salaries and benefits expenses during the quarter ended March 31, 2009, were $129,000 which included non-cash, stock based compensation charges (for the extension of the expiry date of options) of $nil. In the corresponding period of the prior fiscal year, salaries and benefits expenses were $140,999, which included non-cash, stock based compensation charges of $nil.

Research and development costs of $43,234 during the quarter ended March 31, 2009, are attributable to refining the manufacturing process of our ElectriPlast™ material.  In the corresponding period of the prior fiscal year, the amount expensed under this category was $53,317.

For the Nine Months Ended March 31, 2009 compared to the Nine Months Ended March 31, 2008

Our net loss for the nine months ended March 31, 2009, was $1,131,115, compared to a net loss of $1,193,264 for the corresponding period of the prior fiscal year, a modest decrease of $62,149.

Total expenses for the nine months ended March 31, 2009, was $1,138,997 compared to total expenses of $1,246,260 for the corresponding period of the prior fiscal year a reduction of $107,263 which was primarily a result of a reduction in general and administrative expenses of $23,009, travel and entertainment expenses of $34,922 and a reduction of research and development costs of $31,711.

1


Total income for the nine months ended March 31, 2009, was comprised of “other income” of $7,882 compared to “other income” of $52,996 for the corresponding period of the prior fiscal year, a decrease of $45,114.  The category of “other income” consists of interest income and nominal license fees.

Consulting expenses during the nine months ended March 31, 2009, were $194,369 which included non-cash, stock based compensation charges (for the extension of the expiry date of options) of $18,104 and issuance of shares in consideration for consulting services in the amount of $14,000 representing the market value of shares at the date the shares were to be issued. . In the corresponding period of the prior fiscal year, consulting expenses were $204,139, which included non-cash, stock based compensation charges of $nil.

Salaries and benefits expenses during the nine months ended March 31, 2009, were $433,558 which included non-cash, stock based compensation charges (for the extension of the expiry date of options) of $15,531. In the corresponding period of the prior fiscal year, salaries and benefits expenses were $429,260, which included non-cash, stock based compensation charges of $nil.

Research and development costs of $153,549 during the nine months ended March 31, 2009, are attributable to refining the manufacturing process of our ElectriPlast™ material.  In the corresponding period of the prior fiscal year, the amount expensed under this category was $185,260.

For the nine months ended March 31, 2009, our cash used in operating activities was $1,159,775 compared to $1,185,895 used in the corresponding period of the prior fiscal year a decrease of $26,120.

For the nine months ended March 31, 2009, our cash provided by financing activities was $895,200 compared to $208,995 provided in the corresponding period of the prior fiscal year. The difference of $686,205 was due to subscriptions received during the nine months ended March 31, 2009, for the private placement of equity securities in the amount of $895,200.

We anticipate spending up to approximately $250,000 over the next twelve months on ongoing research and development (primarily salaries and consulting fees) of the different applications and uses of our technologies.

During the next twelve months, we do not anticipate increasing our staff.

Since inception we have funded our operations through capital fundraising and loans from management.

As of March 31, 2009, we had $839,529 in cash on hand.  Accordingly, management believes that there is adequate cash on hand to fund operations over the next 4 months and additional equity funding will be required thereafter.

We are not in the manufacturing business and do not expect to make any capital purchases of a manufacturing plant or significant equipment in the next twelve months.

Presently, we are focusing the majority of our resources on the researching, developing and commercializing of our ElectriPlast™ technologies.  Our business strategy focuses on leveraging our intellectual property rights and our strengths in product design and material innovation. We are focusing our marketing efforts on securing licensing agreements for applications of our ElectriPlast™ technologies with manufacturers of products which would benefit from the incorporation of any of the ElectriPlast™ applications.

ElectriPlast™ is an innovative, electrically-conductive resin-based material. The ElectriPlast™ polymer is a compounded formulation of resin-based materials, which are conductively loaded, or doped, with a proprietary-controlled, balanced concentration of micron conductive materials, then pelletized. The conductive loading or doping within this pellet is then homogenized using conventional molding techniques and conventional molding equipment. The end result is a product that can be molded into any of the infinite shapes and sizes associated with plastics and rubbers, and is non-corrosive, but which is as electrically conductive as if it were metal.

Various examples of applications for ElectriPlast™ are shielding, lighting circuitry, switch actuators, resistors, medical devices, thermal management and cable connector bodies, to name just a few. We have been working to introduce these new applications and the ElectriPlast™ technology to the marketplace.

Patents/Trademarks on Technologies

Our intellectual property portfolio consists of over eleven years of accumulated research and design knowledge and trade secrets.  We have sought U.S. patent protection for many of our ideas related to our ElectriPlast™ technologies.  Currently, we have filed 119 U.S. patent applications, 42 of which have been issued and 77 of which have been filed and are pending approval minus 40 which have been rejected to date. No assurances can be given that all patent applications will be approved; however, to the extent that patents are not granted, we will continue to attempt to commercialize these technologies without the protection of patents.  As patents are issued, we will have the exclusive right to use in the U.S. the design(s) described in each issued patent for the 18-year life of the patent.

2


Certain patent office applications have been rejected by the patent office due to more stringent requirements implemented by the patent office over 18 months ago. The Company has elected not to appeal those patent application rejected as the contents of those rejected applications have been incorporated into subsequent applications.

Recent developments in the law increase the challenge of obtaining US patent protection.  In particular, the Supreme Court’s decision in KSR v. Teleflex (2007) makes it easier for the USPTO to sustain obviousness rejections. As a result, the USPTO is now more likely to reject applications by combining elements from the prior art – even where no motivation to combine can be shown in the art references.  This new approach affects all applicants, including Integral Technologies, Inc., and has reduced the rate of patent issues. Nevertheless, Integral Technology, Inc., continues to pursue intellectual property protection through its patent and trademark portfolio while constantly evaluating its filings to judiciously apply resources to the most critical technologies.

We have also filed trademark applications with the U.S. Trademark Office for “ElectriPlast™” and related names such as “ElectriPonix™” and “ElectriOnix™.

Summary descriptions of our manufacturing agreement with Jasper Rubber Products, Inc. and our various patent license agreements are included in our annual report on Form 10-KSB for the year ended June 30, 2008.

We have also filed trademark applications with the U.S. Trademark Office for “ElectriPlast™” and related names such as “ElectriPonix™” and “ElectriOnix™.

We are not in the manufacturing business.  Our manufacturing agreement with Jasper Rubber Products, Inc. provides for Jasper to manufacture ElectriPlast™ for us.

After twenty-three months of refining the manufacturing and molding process of ElectriPlast™, the Jasper facility is now capable of producing over 50,000 pounds of ElectriPlast™ pellets per month.  We have entered into patent license agreements with several companies, as summarized below, and we are in the process of producing prototypes of requested applications of ElectriPlast™ for these companies as well as other prospective customers.

In addition to its manufacturing capabilities, Jasper has a distribution network throughout the US and Canada, allowing for ElectriPlast™ to be introduced to prospective customers and delivered to customers.

We anticipate that our technologies will not be sold directly to the general public, but rather to businesses and manufacturers who will incorporate our technologies as components in the design of their products.

During the nine months ended March 31, 2009, the Company extended the expiration date of 955,000 options.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

N/A.

ITEM 4T. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Pursuant to Rule 13a-15(b) under the Exchange Act the Company carried out an evaluation with the participation of the Company’s management, including William S. Robinson, our Chief Executive Officer (“CEO”) and William A. Ince, our  Company’s Chief Financial Officer (“CFO”), of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the period ended March 31, 2009.  Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

3


Changes in internal controls

Our management, with the participation our Chief Executive Officer and Chief Financial Officer, performed an evaluation as to whether any change in our internal controls over financial reporting  occurred during the quarter ended March 31, 2009.  Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company's internal controls over financial reporting during the 2009 quarter ended March 31, 2009 that has materially affected, or is reasonably likely to materially affect, the Company's internal controls over financial reporting.
 
PART II

OTHER INFORMATION COMPANY CONFIRM OR UPDATE AS NEEDED

ITEM 1 - LEGAL PROCEEDINGS

We are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.   

ITEM 1A. RISK FACTORS

There have been no material changes from the Risk Factors described in our Annual Report on Form 10-KSB for the fiscal year ended June 30, 2008.

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4 - SUBMISSION OF MATTERS TO VOTE OF SECURITY HOLDERS

None.

ITEM 5 - OTHER INFORMATION

None.

ITEM 6. Exhibits

31.1
 
Certification by Chief Executive Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
     
31.2
 
Certification by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
     
32.1
 
Certification by Chief Executive Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code
     
32.2
 
Certification by Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code

4

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


DATE: May 15, 2009
     
 
Integral Technologies, Inc.
 
       
       
 
By:
/s/ William S. Robinson
 
   
William S. Robinson, Chief Executive Officer
   
and Principal Executive Officer
       
 
By:
/s/ William A. Ince
 
   
William A. Ince, Chief Financial Officer and
   
Principal Accounting Officer
       
Date: May 15, 2009
     


EXHIBIT INDEX


 
Certification by Chief Executive Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
     
 
Certification by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act
     
 
Certification by Chief Executive Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code
     
 
Certification by Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code
 
 
5